Scientists at Nagoya University in Japan have made a significant breakthrough in treating lipid disorders.
Galapagos pauses blood cancer CAR-T therapy trial due to one Parkinsonism event
Galapagos has temporarily stopped enrolling patients into an early-phase test in patients with multiple myeloma after a neurological issue was raised. Elsewhere, the biotech expanded